Welcome to our dedicated page for Amdocs SEC filings (Ticker: DOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amdocs Limited SEC filings document the disclosures of a foreign private issuer that provides software and services to communications and media companies. Its Form 6-K reports include quarterly and annual financial materials, consolidated financial statements, operating and financial review, earnings presentations, and disclosures on equity activity and issuer purchases.
The filing record also covers shareholder meeting materials and voting results, including board elections, employee share purchase plan amendments, dividend program approvals, auditor ratification, and governance changes involving executive leadership and board composition. Registration-statement incorporation language connects selected Form 6-K reports to Amdocs' equity compensation filings on Form S-8.
Amdocs Ltd executive Matthew E. Smith reported an open-market sale of company stock. On this Form 4, he sold 464 Ordinary Shares of Amdocs on May 29, 2026 at an average price of $62.51 per share, for roughly $29,000 in proceeds.
After the transaction, Smith directly holds 1,550 Ordinary Shares of Amdocs. The filing reflects a routine insider sale rather than a change in compensation or option exercise, and no derivative securities are reported as remaining positions.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice to sell 50,000 shares of common stock of the issuer on 06/01/2026. The filing states the sale follows an exercise of options under a registered plan and lists proceeds of $3,257,700.00.
DOX reported a proposed resale of 464 shares of Common Stock tied to restricted stock vesting under a registered plan on 05/29/2026.
The notice states the shares are being sold by the issuer in connection with services rendered and reflect vested restricted stock; cash‑flow treatment and buyer details are not included in the excerpt.
Amdocs Limited reported modest revenue growth but lower profit for the six months ended March 31, 2026. Revenue rose 4.0% to $2,327.9M, helped by activity across all regions and recent acquisitions, including Matrixx Software.
Net income attributable to Amdocs fell to $295.4M from $314.4M, and diluted EPS edged down to $2.74 from $2.78, reflecting higher restructuring charges of $21.7M, increased amortization of intangibles and higher income taxes. Operating margin slipped to 16.7% from 17.7%.
Cash from operations strengthened to $321.8M, funding $217.7M of acquisitions, $284.5M of share repurchases and $113.8M of dividends, reducing cash to $214.5M. Twelve-month backlog reached $4.28B, up 2.6%. Amdocs also expanded its revolving credit facility to $800M and set up an $800M commercial paper program.
Amdocs Ltd notice: a Form 144 was filed reporting proposed sales of ordinary shares by an affiliate. The filing lists Restricted Stock Units from 11/15/2019 (46,811 shares) and 11/11/2020 (110,075 shares) and shows recent dispositions of 149,701 and 17,013 shares on 03/18/2026 and 03/19/2026 respectively, with proceeds recorded as 9,752,271.64 and 1,100,838.07.
Hortig Shimie reported acquisition or exercise transactions in this Form 4 filing.
Amdocs Ltd director and officer Shimie Hortig received an equity grant as part of his compensation. On May 13, 2026, he was awarded 84,483 Amdocs ordinary shares at no purchase price, described as time-based restricted stock awards that vest over three years from the grant date.
After this grant, Hortig directly holds 181,696 ordinary shares. Because this is a share award rather than an open-market trade, it reflects routine equity compensation rather than a discretionary stock purchase or sale.
Amdocs Limited reported fiscal Q2 2026 revenue of $1.17 billion, up 3.9% year over year as reported and 2.2% in constant currency. GAAP diluted EPS was $1.28, down from $1.45, while non-GAAP diluted EPS held at $1.78, matching the prior-year quarter.
Non-GAAP operating margin reached 21.5%, up 20 basis points year over year. Twelve‑month backlog rose to $4.28 billion, up about 2.6% from the prior year, supporting revenue visibility. Free cash flow for the quarter was $80 million, and the company returned more than 100% of this through share repurchases and dividends.
For Q3 2026, Amdocs guides revenue to $1.155–$1.195 billion, GAAP EPS of $1.39–$1.47, and non-GAAP EPS of $1.81–$1.87. For full-year 2026, it expects reported revenue growth of 2.6%–4.6%, non-GAAP EPS growth of 5%–7%, and free cash flow of $710–$730 million, reiterating midpoints while tightening ranges.
The company highlights its “agentic” AI strategy and the launch of its aOS operating system, alongside solid managed services revenue and project milestones with major telecom customers. Amdocs also announced the upcoming retirement of long-serving CFO and COO Tamar Rapaport‑Dagim and appointed internal executive Tal Rozenfeld as CFO effective June 1, 2026.
Amdocs Limited reported fiscal Q2 2026 revenue of $1.17 billion, up 3.9% year over year as reported and 2.2% in constant currency. GAAP diluted EPS was $1.28, down from $1.45, while non-GAAP diluted EPS held at $1.78, matching the prior-year quarter.
Non-GAAP operating margin reached 21.5%, up 20 basis points year over year. Twelve‑month backlog rose to $4.28 billion, up about 2.6% from the prior year, supporting revenue visibility. Free cash flow for the quarter was $80 million, and the company returned more than 100% of this through share repurchases and dividends.
For Q3 2026, Amdocs guides revenue to $1.155–$1.195 billion, GAAP EPS of $1.39–$1.47, and non-GAAP EPS of $1.81–$1.87. For full-year 2026, it expects reported revenue growth of 2.6%–4.6%, non-GAAP EPS growth of 5%–7%, and free cash flow of $710–$730 million, reiterating midpoints while tightening ranges.
The company highlights its “agentic” AI strategy and the launch of its aOS operating system, alongside solid managed services revenue and project milestones with major telecom customers. Amdocs also announced the upcoming retirement of long-serving CFO and COO Tamar Rapaport‑Dagim and appointed internal executive Tal Rozenfeld as CFO effective June 1, 2026.
Amdocs Limited reported fiscal Q2 2026 revenue of $1.17 billion, up 3.9% year over year as reported and 2.2% in constant currency. GAAP diluted EPS was $1.28, down from $1.45, while non-GAAP diluted EPS held at $1.78, matching the prior-year quarter.
Non-GAAP operating margin reached 21.5%, up 20 basis points year over year. Twelve‑month backlog rose to $4.28 billion, up about 2.6% from the prior year, supporting revenue visibility. Free cash flow for the quarter was $80 million, and the company returned more than 100% of this through share repurchases and dividends.
For Q3 2026, Amdocs guides revenue to $1.155–$1.195 billion, GAAP EPS of $1.39–$1.47, and non-GAAP EPS of $1.81–$1.87. For full-year 2026, it expects reported revenue growth of 2.6%–4.6%, non-GAAP EPS growth of 5%–7%, and free cash flow of $710–$730 million, reiterating midpoints while tightening ranges.
The company highlights its “agentic” AI strategy and the launch of its aOS operating system, alongside solid managed services revenue and project milestones with major telecom customers. Amdocs also announced the upcoming retirement of long-serving CFO and COO Tamar Rapaport‑Dagim and appointed internal executive Tal Rozenfeld as CFO effective June 1, 2026.
Amdocs Limited reported fiscal Q2 2026 revenue of $1.17 billion, up 3.9% year over year as reported and 2.2% in constant currency. GAAP diluted EPS was $1.28, down from $1.45, while non-GAAP diluted EPS held at $1.78, matching the prior-year quarter.
Non-GAAP operating margin reached 21.5%, up 20 basis points year over year. Twelve‑month backlog rose to $4.28 billion, up about 2.6% from the prior year, supporting revenue visibility. Free cash flow for the quarter was $80 million, and the company returned more than 100% of this through share repurchases and dividends.
For Q3 2026, Amdocs guides revenue to $1.155–$1.195 billion, GAAP EPS of $1.39–$1.47, and non-GAAP EPS of $1.81–$1.87. For full-year 2026, it expects reported revenue growth of 2.6%–4.6%, non-GAAP EPS growth of 5%–7%, and free cash flow of $710–$730 million, reiterating midpoints while tightening ranges.
The company highlights its “agentic” AI strategy and the launch of its aOS operating system, alongside solid managed services revenue and project milestones with major telecom customers. Amdocs also announced the upcoming retirement of long-serving CFO and COO Tamar Rapaport‑Dagim and appointed internal executive Tal Rozenfeld as CFO effective June 1, 2026.
Amdocs Limited reported fiscal Q2 2026 revenue of $1.17 billion, up 3.9% year over year as reported and 2.2% in constant currency. GAAP diluted EPS was $1.28, down from $1.45, while non-GAAP diluted EPS held at $1.78, matching the prior-year quarter.
Non-GAAP operating margin reached 21.5%, up 20 basis points year over year. Twelve‑month backlog rose to $4.28 billion, up about 2.6% from the prior year, supporting revenue visibility. Free cash flow for the quarter was $80 million, and the company returned more than 100% of this through share repurchases and dividends.
For Q3 2026, Amdocs guides revenue to $1.155–$1.195 billion, GAAP EPS of $1.39–$1.47, and non-GAAP EPS of $1.81–$1.87. For full-year 2026, it expects reported revenue growth of 2.6%–4.6%, non-GAAP EPS growth of 5%–7%, and free cash flow of $710–$730 million, reiterating midpoints while tightening ranges.
The company highlights its “agentic” AI strategy and the launch of its aOS operating system, alongside solid managed services revenue and project milestones with major telecom customers. Amdocs also announced the upcoming retirement of long-serving CFO and COO Tamar Rapaport‑Dagim and appointed internal executive Tal Rozenfeld as CFO effective June 1, 2026.
Amdocs Limited reported fiscal Q2 2026 revenue of $1.17 billion, up 3.9% year over year as reported and 2.2% in constant currency. GAAP diluted EPS was $1.28, down from $1.45, while non-GAAP diluted EPS held at $1.78, matching the prior-year quarter.
Non-GAAP operating margin reached 21.5%, up 20 basis points year over year. Twelve‑month backlog rose to $4.28 billion, up about 2.6% from the prior year, supporting revenue visibility. Free cash flow for the quarter was $80 million, and the company returned more than 100% of this through share repurchases and dividends.
For Q3 2026, Amdocs guides revenue to $1.155–$1.195 billion, GAAP EPS of $1.39–$1.47, and non-GAAP EPS of $1.81–$1.87. For full-year 2026, it expects reported revenue growth of 2.6%–4.6%, non-GAAP EPS growth of 5%–7%, and free cash flow of $710–$730 million, reiterating midpoints while tightening ranges.
The company highlights its “agentic” AI strategy and the launch of its aOS operating system, alongside solid managed services revenue and project milestones with major telecom customers. Amdocs also announced the upcoming retirement of long-serving CFO and COO Tamar Rapaport‑Dagim and appointed internal executive Tal Rozenfeld as CFO effective June 1, 2026.
Amdocs Ltd director and officer Hortig Shimie filed an initial ownership report on Ordinary Shares. The filing shows direct ownership of 97,213 Ordinary Shares as of the reported date. The total includes Ordinary Shares that are subject to outstanding restricted stock awards, so some shares are still tied to vesting conditions rather than being fully unrestricted.
Amdocs Limited reported a leadership transition in its management and board. In connection with his retirement from Amdocs’ management team, Shuky Sheffer has also retired from the Board of Directors. The Board has appointed Shimie Hortig as a new director, effective concurrently with his replacement of Mr. Sheffer as President and Chief Executive Officer of Amdocs Management Limited.
The company describes itself as a leading provider of software and services to communications and media companies and reported revenue of $4.53 billion in fiscal 2025. The press release also reiterates standard forward-looking statement language, highlighting risks related to macroeconomic conditions, competition, technology shifts, security incidents and customer spending.
Amdocs Ltd director Sarah R. Davis has filed an initial ownership report showing her current equity stake in the company. The Form 3 discloses direct ownership of 16,488 Ordinary Shares, which include Ordinary Shares underlying outstanding restricted stock units. This filing records her starting position as a director rather than any new share purchase or sale.